Drug: |
Bortezomib + Sunitinib |
|||
---|---|---|---|---|
Trial: |
A Phase I Trial of Bortezomib and Sunitinib |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
Emory Winship Cancer Institute1365C Clifton Road |
Principal Investigator: |
John Kauh, MD |
---|---|
Contact: |
John Kauh, MD 1-888-946-7447 jkauh@emory.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Emory Winship Cancer Institute Website: |
http://cancer.emory.edu/ |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.